In vitro and in vivo activity of LS 4477 and LS 4559, novel analogues of the tubulin binder estramustine
- 1 January 2002
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 38 (1), 194-204
- https://doi.org/10.1016/s0959-8049(01)00341-0
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Interaction of Estramustine with Tubulin IsotypesBiochemistry, 1997
- Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate.Journal of Clinical Oncology, 1994
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1992
- Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and TAUBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1992
- Mechanisms of Action and Clinical Uses of EstramustineCancer Investigation, 1990
- Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: An immunohistochemical studyThe Prostate, 1989
- Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3The Prostate, 1984
- Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the ProstateJournal of Urology, 1981
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- MicrotubulesAnnual Review of Biochemistry, 1973